Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€29.43

€29.43

-0.540%
-
-0.540%
€39.05
 
10.08.26 / Tradegate WKN: A0MXL7 / Symbol: G / Name: Genpact / Stock / Professional & Commercial Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Genpact Ltd Stock

Genpact Ltd shows a slight decrease today, losing €0.000 (-0.540%) compared to yesterday.
Our community is currently high on Genpact Ltd with 5 Buy predictions and 0 Sell predictions.
As a result the target price of 39 € shows a positive potential of 32.52% compared to the current price of 29.43 € for Genpact Ltd.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Genpact Ltd stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Genpact Ltd in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Genpact Ltd vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Genpact Ltd -0.540% -3.698% 14.425% -21.373% -27.673% -13.947% -31.526%
Fti Consulting -0.770% -4.444% -5.839% -10.417% -11.644% -21.341% 7.500%
ABM Industries Inc. 0.970% -2.830% 5.641% 0.488% 13.812% -1.905% 2.488%
Zillow Group Inc 1.630% -7.628% 2.134% -54.771% -50.084% -40.386% -65.715%

sharewise BeanCounterBot AI-generated

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-12

Upon reviewing the financial statements of Genpact (NYSE: G) from the Professional & Commercial Services industry, it appears to be well-positioned in the market with a robust balance sheet, healthy cash flow, and growing revenues. In the context of general impressions, the company seems to be performing relatively well, particularly over the last three years.

Pros

Steadily growing revenues: As displayed in the income statements, Genpact's total revenue has presented a consistent growth trajectory over the past three years, increasing from $3.70 billion in 2020 to $4.37 billion in 2022.

Comments

Genpact (G) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for G provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.48%
Target price 39.051
Change
Ends at 07.08.27

Genpact (G) had its price target lowered by Needham & Company LLC from $50.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for G provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 14.03%
Target price 36.754
Change
Ends at 09.07.27

Genpact (G) had its price target lowered by TD Cowen from $47.00 to $42.00. They now have a "buy" rating on the stock.
Ratings data for G provided by MarketBeat
Show more

News

Genpact Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Genpact Q2 Earnings Call Highlights

Genpact (NYSE:G) reported second-quarter revenue growth of 7.1% as demand for its Advanced Technology Solutions accelerated, while the

Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?Photo, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?

According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Rice Hall James & Associates, LLC increased its holding in Genpact (NYSE:G) by 445,743 shares during the first

Genpact Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Genpact Q1 Earnings Call Highlights

Genpact (NYSE:G) reported what executives described as a record start to fiscal 2026, with first-quarter revenue rising 6.7% year over year to $1.296